Figure 7: Pharmacokinetics of CMD−05 in rats.
From: CMD-05, a novel promising clinical anti-diabetic drug candidate, in vivo and vitro studies
(A) Concentration-time curve following single oral administration of 50 mg/kg CMD-05. (B) Concentration-time curve following single intravenous administration of 50 mg/kg CMD-05. (C) Changes of DPP-IV activity following single oral administration of 4.5 mg/kg CMD-05. Data are expressed as the mean ± SD of four individual animals.
